These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11363191)

  • 21. Abbott agrees to implement a compassionate use program for Ritonavir.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2000 PWAs to get ritonavir via expanded access.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Merck protease inhibitor available to persons with CD4 count 50 or less--must register by August 11.
    AIDS Treat News; 1995 Jul; (no 227):1-2. PubMed ID: 11362618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease inhibitor consensus statement.
    AIDS Treat News; 1995 Mar; (no 219):7. PubMed ID: 11362333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA clearance for ritonavir in children with AIDS.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
    [No Abstract]   [Full Text] [Related]  

  • 27. Europe out of step with the US.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):33-4. PubMed ID: 11363328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abbott: major protest over lack of access.
    AIDS Treat News; 1995 May; (no 223):7. PubMed ID: 11362468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abbott protease inhibitor lottery in January, CD4 under 50--registration now.
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ritonavir expanded access.
    GMHC Treat Issues; 1995 Dec; 9(12):8. PubMed ID: 11363000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ritonavir: expanded access begins, warning on drug interactions.
    James JS
    AIDS Treat News; 1996 Jan; (no 239):4. PubMed ID: 11363086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease inhibitor approved for AIDS treatment.
    AORN J; 1996 Sep; 64(3):453. PubMed ID: 8876926
    [No Abstract]   [Full Text] [Related]  

  • 34. Protease inhibitor studies enrolling.
    Treat Rev; 1995; (no 17):3. PubMed ID: 11362296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Let there be drugs.
    Gilden D
    GMHC Treat Issues; 1996 Feb; 10(2):1, 13-6. PubMed ID: 11363380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kids studies.
    Treat Rev; 1995 Nov; (no 20):7. PubMed ID: 11363029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV therapeutics, continued: another HIV protease inhibitor approved.
    Laurence J
    AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
    [No Abstract]   [Full Text] [Related]  

  • 38. Ritonavir (Norvir).
    Treat Rev; 1996 Apr; (no 21):6. PubMed ID: 11363397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rolling uncertainties of antiprotease prescribing.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):6-10. PubMed ID: 11363341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3TC and protease inhibitors: citizen's petition asks faster approval.
    AIDS Treat News; 1995 Apr; (no 220):5. PubMed ID: 11362321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.